We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
+20.77%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$547M
Cap. Flow
-$10.2M
Cap. Flow %
-1%
Top 10 Hldgs %
88.16%
Holding
123
New
24
Increased
19
Reduced
32
Closed
28

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$4.7M
2
ZGNX
Zogenix, Inc.
ZGNX
+$3.17M
3
WNC icon
Wabash National
WNC
+$1.87M
4
SAGE
Sage Therapeutics
SAGE
+$1.75M
5
PRTA icon
Prothena Corp
PRTA
+$1.53M

Top Sells

Rank Stock Value
1
HIMX
Himax Technologies
HIMX
+$4.17M
2
MB
MINDBODY, Inc. Class A Common Stock
MB
+$2.9M
3
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$2.74M
4
AMD icon
Advanced Micro Devices
AMD
+$2.52M
5
MYND
Mynd.ai
MYND
+$2.28M

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.39%
2 Healthcare 8.29%
3 Technology 2.88%
4 Communication Services 2.01%
5 Consumer Discretionary 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$799B
$470M 45.97%
+1,760,000
New +$458M
QQQ icon
2
PUT
Invesco QQQ Trust
QQQ
$474B
$322M 31.54%
2,069,000
+604,500
+41% +$92.3M
AAPL icon
3
CALL
Apple
AAPL
$4.84T
$42.3M 4.14%
1,000,000
+200,000
+25% +$8.36M
MRNS
4
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$18.6M 1.82%
569,712
-101,500
-15% -$2.74M
HIMX
5
Himax Technologies
HIMX
$2.31B
$9.4M 0.92%
902,100
-384,500
-30% -$4.17M
ADMS
6
DELISTED
Adamas Pharmaceuticals
ADMS
$9.17M 0.9%
270,515
-63,000
-19% -$1.76M
META icon
7
Meta Platforms (Facebook)
META
$1.71T
$8.97M 0.88%
50,850
-7,600
-13% -$1.34M
AXGN icon
8
Axogen
AXGN
$2.42B
$7.75M 0.76%
273,751
– –
GOOS
9
Canada Goose Holdings
GOOS
$724M
$6.82M 0.67%
216,200
+41,200
+24% +$1.01M
ZGNX
10
DELISTED
Zogenix, Inc.
ZGNX
$5.87M 0.57%
146,500
+82,400
+129% +$3.17M
GWPH
11
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$5.28M 0.52%
+40,000
New +$4.7M
NTES icon
12
NetEase
NTES
$76.5B
$5M 0.49%
72,500
+23,500
+48% +$1.47M
GLNG icon
13
Golar LNG
GLNG
$5.14B
$4.47M 0.44%
150,000
+5,000
+3% +$120K
SBBP
14
DELISTED
Strongbridge Biopharma plc.
SBBP
$4.12M 0.4%
567,895
– –
NVDA icon
15
NVIDIA
NVDA
$5.12T
$3.23M 0.32%
668,000
-12,000
-2% -$59.6K
GOOGL icon
16
Alphabet (Google) Class A
GOOGL
$4.22T
$3.16M 0.31%
60,000
+26,000
+76% +$1.34M
SAGE
17
DELISTED
Sage Therapeutics
SAGE
$2.96M 0.29%
+18,000
New +$1.75M
LITE icon
18
Lumentum
LITE
$75.3B
$2.84M 0.28%
58,000
-39,300
-40% -$2.19M
AERI
19
DELISTED
Aerie Pharmaceuticals
AERI
$2.75M 0.27%
46,000
-3,800
-8% -$230K
SMMT icon
20
Summit Therapeutics
SMMT
$13.9B
$2.68M 0.26%
242,113
– –
NPTN
21
DELISTED
NEOPHOTONICS CORP
NPTN
$2.55M 0.25%
388,000
-70,302
-15% -$429K
CEVA icon
22
CEVA Inc
CEVA
$786M
$2.5M 0.24%
54,139
+29,139
+117% +$1.34M
SRPT icon
23
Sarepta Therapeutics
SRPT
$2.19B
$2.46M 0.24%
44,220
-2,300
-5% -$122K
ZAGG
24
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$2.44M 0.24%
132,200
+23,700
+22% +$443K
JPM icon
25
JPMorgan Chase
JPM
$937B
$2.28M 0.22%
21,300
-2,200
-9% -$223K
1
2 3 4 5

Similar funds

MAM
Moelis Asset Management New York $5.32M AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
SM
SG3 Management Dorado, Puerto Rico $6.45K AUM 61.81% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

Granite Point Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Granite Point Capital Management held 123 positions worth $1.02B, up 115% from $475M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Granite Point Capital Management's Q4 2017 filing shows 24 new, 19 increased, 32 reduced and 28 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 40,000 shares worth $5.28M. The largest sale was Himax Technologies, an estimated $4.17M.

By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, up from 65% a quarter earlier, followed by Healthcare and Technology.

  • Granite Point Capital Management's largest Q4 2017 buy was GW Pharmaceuticals Plc American Depositary Shares: 40,000 shares worth $5.28M.
  • Granite Point Capital Management added most to Zogenix, Inc. in Q4 2017, an estimated $3.17M increase.
  • Granite Point Capital Management's biggest Q4 2017 reduction was Himax Technologies, cutting an estimated $4.17M.
  • Granite Point Capital Management fully exited MINDBODY, Inc. Class A Common Stock in Q4 2017, selling an estimated $2.9M.
  • Granite Point Capital Management's ten largest holdings make up 88% of its $1.02B portfolio in Q4 2017.
  • Granite Point Capital Management opened 24 new positions and closed 28 in Q4 2017.
  • Granite Point Capital Management's portfolio value rose 115% quarter-over-quarter to $1.02B.

Based on Granite Point Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.